Literature DB >> 1602393

Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports.

A H Oliveto1, W K Bickel, J R Hughes, P J Shea, S T Higgins, J W Fenwick.   

Abstract

This study evaluated the discriminative stimulus effects of caffeine in humans. Nine normal male and female volunteers (ages 18-28) were trained to discriminate between the methylxanthine central nervous system stimulant caffeine (320 mg/70 kg, p.o.) and placebo. Monetary reinforcers were earned for identifying correctly the letter code associated with each substance. After four training sessions, the ability to discriminate between the two training conditions was tested for 20 sessions (test-of-acquisition). In subjects who met the criterion for discrimination (i.e., greater than or equal to 85% correct responding on greater than or equal to 4 consecutive sessions during the last 10 test-of-acquisition sessions) dose-effect curves for caffeine (0, 56, 100, 180, 240 and 320 mg/70 kg) and for the benzodiazepine triazolam (0, 0.10, 0.32 and 0.56 mg/70 kg) were determined. Seven of the nine subjects learned the caffeine-placebo discrimination and their performance improved across the 20 test-of-acquisition sessions. The training dose of caffeine (320 mg/70 kg) produced stimulant-like self-reports that differed from placebo when the letter codes were identified correctly, but not when the letter codes were identified incorrectly. Novel caffeine doses produced dose-related increases in caffeine-appropriate responding (N = 4), whereas triazolam produced predominantly placebo-appropriate responding (N = 3) and self-reports that differed from both caffeine and placebo. Throughout dose-effect curve determinations, the training dose of caffeine and placebo continued to be identified correctly (range: 84-100% correct responding). These results suggest that a caffeine (320 mg/70 kg)-placebo discrimination 1) can be acquired and maintained, 2) is related to self-reported drug effects if the training conditions are correctly identified and 3) has some pharmacological specificity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602393

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  49 in total

1.  Influence of acute bupropion pre-treatment on the effects of intranasal cocaine.

Authors:  William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Addiction       Date:  2012-02-11       Impact factor: 6.526

2.  Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.

Authors:  Craig R Rush; William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

3.  Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.

Authors:  William W Stoops; J Adam Bennett; Joshua A Lile; Rajkumar J Sevak; Craig R Rush
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-08-28       Impact factor: 5.067

4.  Methamphetamine self-administration in humans during D-amphetamine maintenance.

Authors:  Erika Pike; William W Stoops; Lon R Hays; Paul E A Glaser; Craig R Rush
Journal:  J Clin Psychopharmacol       Date:  2014-12       Impact factor: 3.153

5.  N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order.

Authors:  B Levi Bolin; Joseph L Alcorn; Joshua A Lile; Craig R Rush; Abner O Rayapati; Lon R Hays; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2017-06-29       Impact factor: 4.492

Review 6.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.

Authors:  William W Stoops; John W Blackburn; David A Hudson; Lon R Hays; Craig R Rush
Journal:  Drug Alcohol Depend       Date:  2007-08-24       Impact factor: 4.492

8.  Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine.

Authors:  Erika Pike; William W Stoops; Craig R Rush
Journal:  Pharmacol Biochem Behav       Date:  2016-09-30       Impact factor: 3.533

9.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

10.  The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.

Authors:  Joshua A Lile; William W Stoops; Lon R Hays; Craig R Rush
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.